NPCE Q4 2023 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena

NPCENeuroPace, Inc.

$482M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$18M+40.8% YoY

Gross Profit

$14M75.2% margin

Operating Income

-$5M-28.0% margin

Net Income

-$6M-34.4% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

+9.6%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$108M

Total Liabilities

$87M

Stockholders' Equity

$21M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$13M	+40.8%
Gross Profit	$14M	$9M	+53.9%
Operating Income	-$5M	-$10M	+48.8%
Net Income	-$6M	-$11M	+44.4%